KSMO 2026 - 19th Annual Meeting of the Korean Society of Medical Oncology
2026-09-02 - 2026-09-04 | Grand InterContinental Seoul Parnas, 521, Teheran-ro, Gangnam-gu, Seoul, Korea, Republic of
0000Days00Hrs00Min00SecAdvancing Cancer Care, Restoring Hope and Lives​
KSMO 2026—the 19th Annual Meeting of the Korean Society of Medical Oncology (KSMO) and the 2026 International Conference, held in conjunction with the 14th International Conference of the Federation of Asian Clinical Oncology (FACO), will bring together oncologists, researchers, clinicians, and healthcare professionals from around the world to explore the latest advances in cancer research and clinical oncology.
Held under the theme “Advancing Cancer Care, Restoring Hope and Lives,” the meeting will showcase the latest scientific discoveries, emerging therapies, multidisciplinary approaches to patient care, and innovations designed to improve outcomes for people living with cancer. Alongside a comprehensive educational programme, attendees will have the opportunity to collaborate, exchange ideas, and network with leading experts from across the international oncology community.
Register Now

38th European Congress of Pathology
2026-09-12 - 2026-09-16 | Stockholmsmässan, Mässvägen 1, Stockholm, 125 30, Sweden
0000Days00Hrs00Min00SecThe ESP Congresses are 5-day annual international pathology congresses by the European Society of Pathology and the largest gatherings of pathologists in Europe.
The aim is to provide an up-to-date scientific programme (e.g. keynote lectures, symposia, slide seminars, short courses, discussions) covering all major areas of diagnostic, translational, molecular and investigative pathology. Special emphasis will be put on both the recent discoveries and the reinforcement of close clinicopathological cooperation.
The 38th ECP will be delivered as a hybrid event with both live participation in Stockholm, Sweden and online participation. Speakers and Chairs will participate exclusively on-site.
Here is why you should attend:

All-in-one delegate fee (no sessions/courses to be paid extra)
The opportunity to meet pathologists from over 100 countries around the globe at the biggest pathology conference world-wide
A chance to meet your peers and evaluate research in front of the world’s leading pathology experts
Outstanding keynote lectures
Opportunity to interact with world-renowned speakers and chairs
A world-class platform to exhibit your products and services
Attractive industry sessions
Large part of content available on demand after the congress

Register NowThe core programme is being prepared with a strong input from the ESP Working Groups, ESP-affiliated Societies, Education and Trainee Subcomittees.
Expected educational outcome(s):

Familiarity with all histological and molecular approaches that are essential, according to current evidence, in the management of diseases.
Confidence in managing patients (screening, diagnosing, data reporting, and follow-up therapy) with neoplastic and non-neoplastic disorders that are identified, according to the existing evidence, by pathological procedures.
Identify major pitfalls and possible solutions in the diagnosis of certain clinical situations.
Discuss and integrate the most up-to date knowledge and recent research findings in the field of human pathology.
Identify opportunities for scientific collaborations worldwide.

MICCAI 2026
2026-09-27 - 2026-10-01 | Strasbourg Convention Centre, Pl. de Bordeaux, Strasbourg, 67000, France
0000Days00Hrs00Min00SecMICCAI 2026 (Medical Image Computing and Computer Assisted Intervention) is one of the world’s leading conferences in medical imaging, artificial intelligence, computer-assisted interventions, and healthcare innovation. Bringing together researchers, clinicians, engineers, and industry leaders, the conference showcases the latest advances in medical image analysis, machine learning, robotics, computer vision, and AI-driven healthcare technologies.
Following a recent announcement from the MICCAI Board, the 2026 conference will now take place in Strasbourg, France, having been relocated from its original venue in Abu Dhabi. The conference will continue to offer its renowned scientific programme, networking opportunities, and technology showcases, bringing the international medical imaging community together in person in Strasbourg.
Register Now

BioTechX USA 2026
2026-09-29 - 2026-09-30 | Hynes Convention Center, Boston MA, USA, Boston, MA, United States
Data. AI. Precision. Innovation.
For Pharma, Healthcare & Partners
America’s most exciting biotechnology congress, bridging the gap between pharma, academia and clinicians to foster meaningful collaborations
BioTechX USA covers diagnostics, precision medicine, and digital transformation in pharmaceutical development and healthcare. Now running for the third year, the event continues conversations on the East Coast, maintaining and fostering new relationships with key stakeholders in the healthcare industry.
The two-day event aims to bring together 1,500 global executives, 300 speakers, 100 sponsors and exhibitors, and 50 start-ups.
The BioTechX USA Congress features speakers from the top 50 pharmaceutical companies, biotechs, healthcare systems, and academic groups, with the goal of strengthening collaboration and networking opportunities.
With eight tracks of high-level content, the agenda covers everything from the use and management of multiomic data to the development of personalised therapies, as well as the generation of the data itself. There is also an opportunity to submit a scientific poster, which will be displayed throughout the two days of the event, providing an excellent platform to showcase research in biotechnology and genomics.
At a time when biotech is experiencing exponential growth, BioTechX USA brings together leaders from biotech, pharma, fast-growing industry start-ups, and established solution providers to offer insights into where the industry is heading next.
Register Now

CAP 2026
2026-10-03 - 2026-10-06 | Wynn, Las Vegas, NV, United States
0000Days00Hrs00Min00SecCAP26 is where the future of pathology takes shape; where pathologists gather not just to gain knowledge, but to exchange ideas, build relationships, and reconnect around a shared vision.
The conversations are real, the education is practical, and the sense of belonging is unmistakable. You’re among colleagues who understand the stakes, the challenges, and what it means to be truly focused on patient outcomes.
Register NowThe CAP26 Abstract Program is a competitive program sponsored by the College of American Pathologists (CAP). The program is designed to promote a broad range of research in pathology. It offers pathologists and research scientists the opportunity to present original research to their peers in a poster presentation format.

16th Annual World CB & CDx Summit
2026-10-05 00:00 - 2026-10-08 00:00 (America/New_York) | The Westin Boston Seaport District, 425 Summer Street, Boston, MA, 02210, United States
0000Days00Hrs00Min00SecAccelerating Complex Biomarkers, Novel & Multimodal Endpoints to Fuel Drug-Diagnostic Innovations from Bench-to-Bedside for Global Precision Medicine Access
As regulatory headwinds turn to tailwinds, precision medicine is shifting into a new gear.
Evolving FDA approaches to LDTs and 510(k) pathways are removing long-standing friction, coordinated Rx-Dx launches are gaining pace, ctDNA and MRD are advancing as clinically meaningful endpoints, and reimbursement expansion is improving access to high-value genomic testing. At the same time, innovation in multiplex assays, multi-omics platforms, liquid biopsy, digital pathology, spatial biology, and AI-powered diagnostics, are rapidly reshaping the IVD landscape.
Fueled by $60B+ in diagnostic deal-making and strategic partnerships, the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns as the industry’s esteemed end-to-end precision medicine forum. Convening 850+ senior leaders from biopharma, diagnostic, regulatory, healthcare, testing labs and multimodal communities, with expertise spanning the full value chain, gain the insights, partnerships and insider know-how to prime your team for continued clinical and commercial success.
With the race to bring scalable, accessible drug-diagnostic programs from bench-to-bedside heating up, join us in harnessing the speed, scale, and growing complexity of innovation happening in next-generation IVD platforms, multimodal data, and CDx development.
Register Now

Delve into the Brand-New Agenda

Free* Attendance for Representatives from Biopharma & Academia
Your Globally Leading Biomarker & Companion Diagnostics Forum
Access Numerous Strategic Rx-Dx Co-Development & Partnership Selection Panels
Partake in Multiple Biomarker Sessions Spanning Oncology, Hematology & Neurological, Chronic, Autoimmune & Rare Diseases
Discover Brand-New Case Studies on Digital Pathology, Multimodal Data & AI-Enabled Precision Medicine
Take Advantage of Unmatched, Exclusive Networking & Partnerships Opportunities

CancerCare 2026: The Convenzis NHS Oncology Conference
2026-10-06 08:30 - 18:30 UTC | The Studio, 3rd Floor, Birmingham, 3rd Floor, 7 Cannon St, Birmingham, B2 5EP, United Kingdom
0000Days00Hrs00Min00SecClinical Diagnostics & Medical Sciences
A Learning-Focused Summit on NHS Oncology
Cancer remains one of the NHS’s most complex and urgent challenges demanding faster diagnosis, more equitable access to treatment, and a workforce confident in delivering precision care. The 10 Year Health Plan places early detection, innovation and personalisation at the heart of future oncology services. This summit responds directly to that call, providing the education, skills and tools NHS professionals need to deliver cancer care that is proactive, personalised and closer to home.
Educational Focus:
Through a mix of Skill Clinics, Lessons Learned Sessions, and Peer Learning Circles, delegates will learn using real-world frameworks, tools, and templates to strengthen early detection pathways, expand genomic testing, and deliver community-based oncology care.
The focus is not on what to achieve, but how to achieve it. Senior leaders and clinicians will share first-hand insights on implementation challenges, course corrections and replicable improvement models that can be applied immediately within local systems.
Key Topics:

Expanding targeted screening, self-sampling and early detection initiatives.
Scaling genomic testing and AI-guided personalised oncology care.
Integrating innovative technologies; including liquid biopsies, cancer vaccines and whole genome sequencing
Redesigning oncology pathways to deliver diagnostics, rehabilitation and follow-up care within community settings.
Accelerating treatment through digital integration, data-driven coordination and insights from precision and immunotherapy trials.

Register NowWhat’s New for 2026:

Morning and Afternoon Skill Clinics: immersive sessions providing delegates with practical templates for screening pathway redesign, genomic testing workflows and community-based cancer care models.
Lessons Learned Sessions: senior NHS leaders share where implementation plans faced challenges and what changes delivered success.
Peer Learning Circles: facilitated, topic-specific discussions connecting oncology teams, commissioners and innovation leads across the UK.
Action-Driven Case Studies: focused on the how: methods, processes and team structures that made progress possible.

Why Attend:

Build confidence through structured, applied learning and guided skill development.
Gain access to replicable frameworks for early diagnosis, genomic testing and localised cancer care delivery.
Hear directly from peers navigating similar workforce, innovation and integration challenges.
Leave with practical artefacts, toolkits, checklists and action plans ready to use within your organisation.
Strengthen your professional network through collaborative learning and best practice sharing across regions and specialties.

Who Would Benefit:
This summit is ideal for oncology service leads, cancer nurse specialists, diagnostic and genomic programme managers, community health directors and primary care leaders working to deliver more personalised, efficient and equitable cancer care. It will also benefit commissioners, clinical directors and innovation leads seeking practical insight into how to scale early detection, accelerate innovation and integrate cancer services into local care systems.
Suppliers, research partners and technology innovators will gain a clear understanding of the operational priorities shaping the next decade of NHS oncology transformation.

CancerCare 2026: The NHS Oncology Conference
2026-10-06 08:30 - 18:30 UTC | etc.venues, Prospero House, London, 241 Borough High St, London, SE1 1GA, United Kingdom
0000Days00Hrs00Min00SecClinical Diagnostics & Medical SciencesA Strategic Conference on Advancing Oncology Pathways Across the NHS – All Convenzis Events Provide 8 CPD Points Per DelegateCancer remains one of the NHS’s most complex and urgent challenges demanding faster diagnosis, more equitable access to treatment, and a workforce confident in delivering precision care. The 10 Year Health Plan places early detection, innovation, and personalisation at the heart of future oncology services.
The NHS Oncology Conference provides a strategic forum for leaders to address these challenges together, translating policy ambition into practical delivery. This event brings NHS teams, ICSs, and cancer alliances together to exchange tested models, frameworks, and collaborative solutions to strengthen early detection, scale genomics, and integrate personalised oncology care within community settings.
Register NowSummit Focus:The NHS Oncology Conference is a premier event for sharing best practices and innovations, designed to help NHS professionals move from awareness to applied implementation. Delegates will gain hands-on frameworks, tested delivery models, and peer-derived insights on how to embed safe, equitable, and sustainable transformation within their services.
Dedicated Skill Clinics offer practical tools, checklists, and implementation templates to support cancer pathway redesign, genomic testing integration, and workforce capability development.
Lessons Learned Sessions provide candid reflections from NHS leaders on real-world challenges, highlighting where implementation plans required adjustment and what delivered measurable results.
This is not a showcase of what to achieve, but a skills exchange on how to achieve it, translating national ambition into measurable improvement.
This year’s event is structured around clear outcomes. Delegates will leave understanding:

Enhance early detection through targeted screening, self-sampling, and expanded genetic testing.
Accelerate innovation by adopting technologies like cancer vaccines, liquid biopsies, and whole genome sequencing.
Advance personalised care using genomics and AI to guide tailored treatments.
Expand community-based oncology, integrating diagnostics, rehab, and follow-up care into local health centres.
Strengthen resilience through digital transformation, workforce capability, and robust governance.
Improve access and equity across cancer pathways, including prostate cancer and haematology services.

What’s New for 2026:
Morning & Afternoon Skill Clinics: immersive sessions focused on actionable tools, checklists, and templates delegates can implement immediately within oncology services.
Lessons Learned Sessions: real-world reflections from NHS leaders detailing what went wrong, what changed, and what succeeded in implementing cancer pathway transformation.
Peer Learning Circles: small-group exchanges enabling collaboration between cancer alliances, ICBs, and provider teams to co-design practical solutions.
Action-Driven Case Studies: focusing on the delivery process — how genomic testing, data integration, and workforce innovation created measurable outcomes.

Why Attend:
Earn 8 CPD Points by attending.
Build professional confidence through applied, hands-on learning.
Access ready-to-use frameworks for early detection, genomic integration, and pathway transformation.
Hear directly from NHS leaders and peers driving oncology service improvement.
Leave with practical artefacts, toolkits, and implementation plans ready for local rollout.
Join a national community of NHS professionals committed to capability-building and sustainable cancer care delivery.

Who Would Benefit:This conference is ideal for clinical, operational, and strategic leaders involved in oncology transformation, including Cancer Alliance leads, oncology service managers, diagnostic and genomic programme directors, Chief Nurses, CCIOs, CIOs, AHP leads, and ICB or ICS transformation teams. It will also benefit commissioners, community health directors, and primary care leaders seeking practical guidance on scalable, interoperable models of cancer care.
Suppliers, research partners, and technology collaborators will gain insight into NHS oncology priorities, workforce capability needs, and the practical enablers shaping the next decade of personalised cancer care.

Biomarkers, CDx & Precision Medicine Europe 2026
2026-10-13 - 2026-10-14 | Congress Center Basel, Messeplatz 21, Basel, CH-4058, Switzerland
0000Days00Hrs00Min00SecA new pathway to patient impact.
Targeted therapies are reframing the outlook for human health creating unprecedented scope for life-changing targeted treatments.
Are you ready to participate in this shared opportunity? Do you have the knowledge, strategy, tools and connections in place?
Precision Medicine provides the platform for you to learn, engage and collaborate across the entire targeted therapy R&D ecosystem — an interdisciplinary community of specialists in pharma, biotech, academia and healthcare.
The event will feature three core programs:

Biomarkers & Companion Diagnostics– Focusing on the discovery, validation, and application of biomarkers in personalized healthcare.
Spatial Biology for Precision Medicine – Highlighting the importance of spatial insights in the development of precision therapies.
Computational Pathology & AI for Precision Diagnostics– Exploring the integration of digital pathology and artificial intelligence in transforming clinical diagnostics.

Register Now

Why attend?

Expand your knowledge
Let subject specialists take you further and deeper.
With comprehensive learning in oncology, neuroscience and key complementary areas.
Build the partnerships you need
Identify, meet and collaborate with the people your strategy requires.
Start working with those who share your goals with 200 hours of pre-arranged 1-2-1s.
Join the conversation
Meet like-minded peers, expand your network and engage in interdisciplinary discussion on the latest thinking and practice.
See what’s in the pipeline
Our events are where innovations land.
Be at the showcase and meet the people behind technologies to give you the edge.
Understand the competitive landscape
Learn what others in your field are doing.
Evaluate their successes (and failures) and set your own benchmarks.
Harness AI & machine learning
AI & machine-learning tools will be critical in unlocking growth.
See the technology in action and speak to those who can help you implement it.

4th Spatial Biology Congress: Asia 2026
2026-10-13 - 2026-10-14 | Lee Kong Chian School of Medicine – NTU Singapore (Novena Campus), Singapore
0000Days00Hrs00Min00SecThe 4th Spatial Biology Congress Asia brings together leaders in spatial biology, imaging, bioinformatics, and multi-omics technologies to explore the latest methods and applications transforming biological insights and translational medicine.
Over two days, delegates will benefit from expert-led presentations, panel discussions, and interactive sessions focused on the latest innovations in spatial biology, from high-plex imaging and complex datasets to cutting-edge analysis pipelines. The programme will also explore how these advances are supporting biomarker discovery, disease research, and clinical applications.
Why Attend?

Gain insights from leading researchers, clinicians and industry innovators sharing the latest breakthroughs in the field of spatial biology
Exposure to the latest advances in spatial transcriptomics, proteomics, and imaging have transformed translational medicine
Case studies demonstrating how spatial data informs disease stratification, biomarker validation, and clinical workflows
Connect with fellow peers, and solution providers through interactive sessions, panel discussions, and dedicated networking opportunities to foster collaboration

Register Now

Pathology Visions 26
2026-10-16 - 2026-10-18 | Manchester Grand Hyatt, San Diego, United States
0000Days00Hrs00Min00SecElevate Patient Care: Discover the Power of DP & AI
Pathology Visions unites 1,000+ digital pathology experts and peers tackling today’s challenges and shaping tomorrow’s innovations.
Engage in practical discussions, explore real-world applications, and gain actionable insights you can implement immediately.
Whether you’re a seasoned expert or an emerging professional, PathVisions offers a collaborative platform for learning and growth.
Don’t just keep up with change, lead it. Discover your place at PathVisions.
Register Now

ESMO Congress 2026
2026-10-23 - 2026-10-27 | IFEMA MADRID, Avda. Del Partenón, 5, Madrid, 28042, Spain
0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology meeting for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2026 will be a platform for breakthroughs in oncology research, clinical practice and patient care.
Participants can expect impactful new data, interactive education, excellent networking opportunities and an innovative exhibition area. By attending the ESMO Congress 2026, oncologists will not only gain insights into the latest developments but also play an active role in shaping the future of oncology on a global scale.
Register NowA comprehensive educational and scientific programme will foster the exchange and debate of translational cancer science, highlight the first announcements of potentially practice-changing data, and stimulate multidisciplinary discussions aimed at improving treatment options for patients.
Learning objectives

To stay informed about current approaches in cancer prevention, screening, and early detection
To gain insights into the latest advances in basic, translational, and clinical cancer research
To explore the clinical implications of scientific breakthroughs in cancer biology, diagnostics, and treatment
To be updated on state-of-the-art therapeutic strategies for patients with cancer
To examine the emerging role of artificial intelligence in cancer diagnosis, research and therapy

ESOI Touchdown 2026
2026-10-29 - 2026-10-31 | DKFZ Heidelberg, Im Neuenheimer Feld 280, Heidelberg, 69120, Germany
0000Days00Hrs00Min00Sec
ESOI Touchdown 2026 brings together radiologists, clinicians, scientists, patients, and industry partners, the meeting will explore the latest advances in oncologic imaging.
The scientific programme will cover a wide range of topics, including artificial intelligence, innovative imaging strategies, multidisciplinary cancer care, cancer screening, therapy-related toxicities, and the future of oncologic reporting. Alongside expert presentations, attendees can take part in interactive workshops and multidisciplinary case discussions, providing valuable opportunities for practical learning, collaboration, and networking within the international oncology imaging community.

Register Now

Highlights

Signal to Decision: How AI Is Transforming Radiology into the Engine of Integrated Oncologic Diagnostics
Keynote Lecture: Individualising Oncologic Diagnostics: The Transformative Power of Liquid Biopsy
Cancer of Unknown Primary – Imaging at the Diagnostic Frontier
Stop Writing Novels: The Future of Radiology Reporting
Bridging Science and Care: Partnership of Patients, Clinicians and Scientists
Neuroendocrine Tumors
Innovations in Cancer Screening
Dark side of the Treatment: Imaging Toxicities of Contemporary Cancer Therapy

MDT Sessions

Lung Cancer MDT
Urogenital Cancer MDT
Gynecological Oncology MDT

Workshops

MRI Characterization of Ovarian Masses
Bone Metastasis & Their Mimics
Imaging in Hematologic Malignancies
Patient Communication for Radiologists
Primary Liver Malignancies: Imaging for Detection and Treatment Planning
Challenges in Head & Neck Imaging
Prostate Cancer: From PI-RADS to Individualized Care
Communication of Scientific Results: How to present yourself

ASDP 2026 Singapore | Asian Society of Digital Pathology 3rd Annual Congress
2026-11-01 - 2026-11-03 | Academia, Singapore General Hospital, 20 College Rd, Singapore, 169856, Singapore
0000Days00Hrs00Min00SecBringing together forward-thinking pathologists, researchers, healthcare executives, and solution providers from across Asia and beyond – hosted in Singapore in November 2026.
Intelligence in Every Pixel: Powering Next Generation Pathology
Annual Congress of the Asian Society of Digital Pathology (ASDP) serves as a unique platform where leaders in digital pathology, computational science, clinical practice, and industry innovation converge.
Building on the success of the first congress in Seoul (2024) and the second congress in Mumbai (2025), the third congress in Singapore in 2026 will bring together pathologists, computer scientists, researchers, industry and policy makers from across the world to explore the latest advances in digital pathology, artificial intelligence, computational imaging and precision diagnostics.
Register NowASDP 2026 is proudly hosted by the Singapore Division of the International Academy of Pathology (SGIAP) and SingHealth Pathology Academic Clinical Programme (SingHealth PATH ACP).

UK NEQAS Annual Participant Meeting 2026
2026-11-03 | America Square, London, United Kingdom
0000Days00Hrs00Min00SecThe UK NEQAS CPT Annual Participant Meeting brings together cellular pathology professionals, laboratory scientists, and quality assurance experts to explore the latest developments in external quality assessment (EQA), laboratory best practice, and diagnostic innovation. The meeting provides an opportunity for participants to hear updates from the UK NEQAS CPT team, learn about emerging techniques and technologies, and gain practical insights from keynote speakers working across the field of cellular pathology.
Alongside the scientific programme, the event encourages discussion, knowledge sharing, and networking between laboratories, industry partners, and healthcare professionals, supporting continuous professional development and the ongoing improvement of quality standards in diagnostic pathology.
Register Now

Med4Nexus Exhibition & Summit UK 2026
2026-11-04 - 2026-11-05 | QEII Centre, London, UK, London, United Kingdom
0000Days00Hrs00Min00SecWhere Biotech, AI, Digital Health & Connected Care Converge
The integrated healthcare event tracing the complete patient pathway, from molecular diagnostics through clinical intelligence to targeted treatment.
Over two days, connect with 2,500+ NHS decision-makers, laboratory directors, digital health executives, clinicians, academia, pathologists, biopharma leaders and investors.
Healthcare is at a pivotal moment. Innovation in biotechnology, AI, digital health, and connected care is converging amid rapid system digitisation, growing investment, and workforce pressures. Med4Nexus provides the platform where healthcare leaders, laboratories, and innovators collaborate to share insight and accelerate technologies that deliver real-world impact for patients and providers.
Register NowConference Themes & Format
At the heart of Med4Nexus Exhibition & Summit is a CPD-accredited conference programme featuring a main stage, breakout sessions and specialist side events, all designed to examine how new tools, diagnostics, digital platforms and therapeutic innovations perform within real clinical environments. The programme focuses on how innovation enhances patient outcomes, strengthens diagnostic pathways, streamlines operational performance and supports service redesign; bridging the gap between emerging solutions and real-world implementation across the NHS.

9th Annual Meeting: Association of Breast Pathology
2026-11-27 00:00 - 2026-11-28 00:00 (Europe/London) | The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE, United Kingdom
0000Days00Hrs00Min00Sec

It’s a great opportunity to learn from experts, share experiences and connect with colleagues from across the field.

Join the Association of Breast Pathology for one and a half days of engaging talks, practical lectures, case-based discussions and the latest updates in breast pathology.

Programme Highlights

WHO guidelines update
Update on fibroepithelial lesions
How to score Ki-67
Triple negative and ER-low breast cancer
Everyday dilemmas in breast pathology
and much more…

Register Now

Digital Pathology and AI Congress: Europe 2026
2026-12-09 - 2026-12-10 | Novotel London West, 1 Shortlands, Hammersmith, London, W6 8DR, United Kingdom
0000Days00Hrs00Min00SecThis internationally recognised meeting brings together 600+ attendees and 60+ technology providers to discuss and collaborate on the latest advances, developments and case studies in the Digital Pathology & AI field. As digital workflows become the norm, the focus now turns to refining digital workflows and how the future of Digital Pathology & AI may lead us to precision medicine approaches for disease treatment.
As a part of the 2025 meeting, attendees discovered how to overcome potential challenges with LIMS and digital workflows, learned about Digital Pathology and AI integration in clinical trials and found out about the return on investment when implementing Digital Pathology. Plus, we explored AI regulation and the ethics of using the technology.
At the heart of our conference lies an unparalleled opportunity to connect. With over seven hours dedicated exclusively to networking, participants have the time and space to engage deeply with peers, share ideas, and spark meaningful collaborations. These interactions are where breakthroughs begin — fostering connections that drive collaborative innovation and discovery.
Register Now

Precision Medicine World Conference 2027
2027-01-27 - 2027-01-29 | Santa Clara Convention Center, 5001 Great America Pkwy, Santa Clara, CA, 95054, United States
0000Days00Hrs00Min00SecThe Davos of Precision Medicine. Driving the future of patient care.
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization & collaboration in an effort to accelerate the development and spread of precision medicine.
Since 2009, recognized as a vital cornerstone for all constituents of the health care and biotechnology community, PMWC provides an exceptional forum for the exchange of information about the latest advances in technology (e.g. DNA sequencing technology), in clinical implementation (e.g. cancer and beyond), research, and in all aspects related to the regulatory and reimbursement sectors.
Register Now
